gimli

3BBLACKBIO stock AI analysis

3BBLACKBIO Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers

3B BLACKBIO DX LTD. is a small-cap stock in Healthcare. This Gimli page shows the latest available 3BBLACKBIO price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.

Analyze with AI Open interactive 3BBLACKBIO stock page

Price

₹1,319.30

1W return

-8.59%

1M return

+14.88%

3M return

+9.84%

6M return

n/a

1Y return

n/a

Market cap

₹n/a

n/a

ROE

+19.89%

ROCE

+25.48%

RSI

46.61

Turnover

₹0.89 cr

Why it can matter in screens

Momentum: 3BBLACKBIO is above 50DMA, below 200DMA; RSI is 46.61.
Returns: 1D +2.21%, 1W -8.59%, 1M +14.88%, 3M +9.84%, 1Y n/a.
Trend levels: 52W high ₹1,588.90, 52W low ₹1,085.00, off high -16.97%.
Liquidity: latest turnover is ₹0.89 cr; volume vs 20D is +0.31%.
Valuation/profitability: PE n/a, PB n/a, ROE +19.89%, ROCE +25.48%.
Growth: 3Y sales CAGR +28.68%, 3Y profit CAGR +30.40%.

Quick Answers

What is the latest 3BBLACKBIO stock price?

The latest stored price for 3BBLACKBIO is Rs 1,319.30 as of 2026-09-18.

Is 3BBLACKBIO above its 50DMA and 200DMA?

3BBLACKBIO is above 50DMA, below 200DMA. The latest 50DMA is 1,293.44 and the latest 200DMA is n/a.

What are 3BBLACKBIO PE, ROE and ROCE?

3BBLACKBIO has PE n/a, ROE +19.89%, and ROCE +25.48% in Gimli's latest available snapshot.

How has 3BBLACKBIO performed recently?

3BBLACKBIO has returned +14.88% over 1 month, +9.84% over 3 months, and n/a over 12 months in the latest stored data.

Is this stock page investment advice?

No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.

Financials and Ownership

Quarterly income statement

Period	Revenue	EBITDA	PAT	EPS
2026-03-31	45.58 cr	18.64 cr	9.80 cr	11.44
2025-12-31	55.94 cr	27.31 cr	22.44 cr	26.19
2025-09-30	39.41 cr	20.24 cr	15.04 cr	17.55
2025-06-30	26.55 cr	16.15 cr	12.64 cr	14.76
2025-03-31	22.50 cr	12.86 cr	8.40 cr	n/a

Annual income statement

Year	Revenue	EBITDA	PAT	EPS
2026-03-31	141.92 cr	82.33 cr	58.59 cr	69.94
2025-03-31	105.56 cr	64.88 cr	47.56 cr	55.66
2024-03-31	83.04 cr	47.43 cr	34.21 cr	37.46
2023-03-31	66.60 cr	36.84 cr	26.42 cr	30.27
2022-03-31	25.62 cr	8.86 cr	8.01 cr	nan

Balance sheet

Period	Assets	Cash	Debt	Equity
2026-03-31	378.00 cr	38.31 cr	3.11 cr	331.64 cr
2025-03-31	295.72 cr	12.47 cr	0.31 cr	271.00 cr
2024-03-31	248.10 cr	12.92 cr	0.79 cr	225.47 cr
2023-03-31	214.06 cr	5.24 cr	2.03 cr	195.91 cr

Cash flow

Period	OCF	FCF	Cash change
2026-03-31	52.48 cr	26.97 cr	n/a
2025-03-31	43.36 cr	42.45 cr	n/a
2024-03-31	26.95 cr	26.44 cr	n/a
2023-03-31	20.28 cr	18.26 cr	n/a
2022-03-31	n/a	n/a	n/a

Shareholding Trend

No recent data available.

Industry Peers

Symbol	Name	Mcap	PE	ROE	1Y
SUNPHARMA	SUN PHARMACEUTICAL IND L	440,829.82 cr	36.388220	+15.50%	+11.45%
DIVISLAB	DIVI S LABORATORIES LTD	248,876.81 cr	85.407280	+18.37%	+53.39%
TORNTPHARM	TORRENT PHARMACEUTICALS L	163,807.57 cr	75.106636	+17.33%	+35.67%
APOLLOHOSP	APOLLO HOSPITALS ENTER. L	128,608.22 cr	65.670049	+21.03%	+13.94%
ZYDUSLIFE	ZYDUS LIFESCIENCES LTD	116,723.14 cr	26.011308	+16.04%	+10.70%
CIPLA	CIPLA LTD	112,647.78 cr	33.401961	+10.25%	-11.64%
LAURUSLABS	LAURUS LABS LIMITED	105,487.98 cr	96.587446	+21.77%	+111.64%
MAXHEALTH	MAX HEALTHCARE INS LTD	102,122.47 cr	70.799892	+14.33%	-10.58%

Try these prompts

Analyze 3B BLACKBIO DX. with valuation, momentum and industry peers
Compare 3BBLACKBIO with other Healthcare stocks
Show small-cap stocks in Healthcare above 50DMA with positive 1M return
Find Healthcare stocks with improving momentum and reasonable valuation

Related screen ideas

Data snapshot: 2026-09-18. Not investment advice.